Cheap on paper, cash-trapped in practice · +13.6% to an operating ceiling, not a target
Below the DCF ceiling, but the minority never sees the cash — WatchlistOperating intrinsic NT$60.67/share (a CEILING — after a 25% governance haircut; pre-haircut NT$80.90) vs market NT$53.40 — only +13.6%, and the FCFF the DCF discounts is cash a minority does not receive. A Tsai-family-controlled (~58.5%) appliance brand that cut its cash dividend ~90% and is parking retained cash in insurer subordinated bonds. The Monte Carlo p5 sits at NT$51.09 — slightly below today's price — and P(intrinsic<market)=12%: the modeled margin/β spread genuinely brackets the price. With cash-return condition A failing and catalyst condition B weak, the realistic call is WATCHLIST pending a dividend restoration or a governance catalyst.
What it sells, where it sells
Operating segments
Air conditioners are ~70% of revenue, so this is a single-product, single-market story — the lone growth lever is the YAMADA value-tier AC brand (~10% of revenue, +50% YoY), which buys volume by deliberately diluting mix rather than expanding the profit pool.
Country mix (revenue-weighted CRP input)
Effectively 100% Taiwan domestic — management confirmed on the Apr-2026 call there are no concrete overseas/OEM plans, so demand is a single mature, saturated home market with no geographic diversification to cushion it. Only secondary exposure is imported components (compressors/panels from CN/JP/KR), a COGS/FX line handled in the flows, not a sovereign re-rating.
Background — five things to know before the case
Context the share price doesn't carry on its face. Skim this once and the bull / bear bullets below stop reading as inside baseball.
- A decade of flat revenue — the thesis is margins and capital allocation, not growth. The top line has been range-bound around NT$6.4B for 5+ years (FY25 NT$6.47B, +0.8% YoY); there is no structural growth story. ~100% Taiwan domestic, AC ~70% of revenue, in a mature, saturated market with one analyst covering it and zero submitted estimates.
- Margins halved, then optically recovered on FX. Operating margin ran ~18% (2020 peak) → 6.9% (2024 trough) → 8.3% (2025), and the 2025 uptick is largely TWD-strength flattering imported-component costs — a non-durable tailwind. EPS fell from NT$12.73 (2020) to ~NT$5.63 (2025), roughly −16%/yr over five years.
- Cash dividend cut ~90% — the dividend-aristocrat narrative is gone. The cash payout dropped from ~NT$4.00/yr (≈7% yield, 2019-24) to ~NT$0.70/yr (now a ~0.8% cash yield), with management shifting to stock dividends (NT$0.80/sh in H2-25, +7M shares) that dilute cash-per-share. The stock is −27% 1Y / −43% 5Y while the TW Electronic index returned +187% over 1Y.
- Tsai family controls ~58.5% via a holdco web — with heavy share pledging. Control runs through private holding companies (Hefa 13.0%, Heran Tech 8.94%, etc.) with 49-83% of key vehicles pledged. The board is only 3/7 independent with no new directors in three years. Founder Tsai Chin-Tu handed the chair to Tsai Po-Yi in Mar-2024.
- Retained cash is flowing into financial assets, not core reinvestment or minorities. A NT$600M subscription (May-2026) to TransGlobe Life Insurance subordinated bonds = ~12.5% of equity; equity-method, FVOCI and short-term investments together ≈ 35% of equity. Genuinely cheap on the screen (P/B ~0.95, P/E ~9, FCF yield ~8.7%) and net-debt-neutral — but the cash is being trapped, not returned.
Where we diverge from the sector
Each row asks: if we'd used the sector median for this one assumption instead of our override, how much would the share price change? Negative = our override is more conservative (worth less); positive = more aggressive (worth more). Skim down the rightmost column to see which bets are doing the work.
The story & the five claims
The 10-year story this DCF is built on, plus the five anchor claims that translate the story into engine inputs.
The 10-year story
Heran is a mature Taiwanese appliance brand — air conditioners are about 70% of revenue — whose top line has been stuck near NT$6.4B for a decade, so there is no growth story; the only question is margins and what management does with the cash. The base case disciplines both downward: revenue creeps up about 2% a year as the YAMADA value brand adds volume, fading to roughly 1.5% in the long run, while operating margin drifts to 7.5% — below the FX-flattered 8.3% of 2025 and nowhere near the ~18% the company earned at its 2020 peak, because that margin regime was reset by cheaper competition and the deliberate shift to lower-price product. That produces a pre-governance value of about NT$81 a share. But this is a family-controlled company (the Tsai family owns ~58.5%) that just cut its cash dividend by roughly 90% and is parking the retained cash in insurer subordinated bonds rather than returning it, so a 25% governance haircut brings the value to about NT$61 — and even that NT$61 is a ceiling, because it discounts free cash flow that a minority shareholder simply does not receive. At NT$53.40 the stock screens cheap (below book, P/E around 9), but the gap to the ceiling is only ~14% and the Monte Carlo's 5th-percentile outcome sits below today's price. Until the dividend is restored or a real governance catalyst appears, the honest call is to watch, not to buy.
Two debates worth pressure-testing
- The FCFF intrinsic is a ceiling, not a target. The screen reads cheap (below book, P/E ~9), but the DCF discounts free cash flow the controlling family is not distributing. A minority realizes only a ~0.8% cash dividend (~0.6% net of ~21% TW withholding) — so the cash-to-minority value sits far below the NT$60.67 operating ceiling.
- The 2025 margin uptick is FX, not a turn. Sell-side optimism on the 8.3% operating margin ignores that it is largely TWD-strength flattering imported-component costs; a weaker TWD compresses it back. We model 7.5%, below the flattered base.
- β set to 1.05 by sector-anti-suppression, not the 0.24 regression. The raw 5Y regression β (~0.24, tight across sources) is a thin-trade micro-cap suppression artifact (~NT$5M/day turnover); we anchor to the re-levered ~1.39 cohort and shade down for staple-demand defensiveness, lifting WACC honestly to 6.65% rather than flattering value with a near-zero β.
- Governance modeled in the flows AND a 25% residual. No margin recovery and reinvestment drag are in the cash flows; the 25% residual (council-raised from 0.20 — "a rounding error against a 90% dividend cut") then carries the pledging, stock-dividend dilution and capital-misallocation leakage the FCFF engine cannot capture.
- The financial-asset pile is NOT added to the target. The ~35%-of-equity financial assets (incl. the 27.27% Taiwan Gree stake) are trapped assets the family is growing, not distributing — adding them would phantom-double-count vs the FCFF output. They form the NAV ceiling, not the operating target.
- The cash never comes. The base bear case is simply the status quo: the dividend stays cut, retained cash keeps flowing into insurer subordinated bonds, and the minority compounds at a ~0.8% cash yield while the family controls a below-book, asset-rich shell. The DCF ceiling is irrelevant if the cash is permanently trapped.
- Margins are at the new normal, or lower. If 7.5% is generous and the value-mix YAMADA shift plus FX reversal pushes the durable margin toward the 6.9% trough, the operating ceiling itself drops below today's price. The MC p5 (NT$51.09) already sits below NT$53.40.
- Stock-dividend dilution keeps grinding cash-per-share down. The shift from cash to stock dividends (+7M shares in H2-25) mechanically dilutes the per-share claim every year it continues.
- Pledging is a forced-selling tail. 49-83% of the key controlling holdcos are pledged; a sharp drawdown could force selling and an air-pocket in a NT$5M/day-turnover micro-cap.
- One analyst, zero estimates — no catalyst for re-rating. Deeply under-covered with no Value-Up plan, no activist, no merger; YAMADA is an operational catalyst, not a governance one. Cheapness can persist indefinitely without a cash-return trigger.
Risks to thesis (tail, not bear case)
The core risk. With a ~90% cash-dividend cut and retained cash flowing into insurer subordinated bonds, the minority cannot realize the FCFF the DCF discounts. Absent a dividend restoration or governance catalyst, the cheap screen is a value trap, not a margin of safety.
If 7.5% is generous — FX reverses and the YAMADA value-mix bites harder toward the 6.9% trough — the operating ceiling drops below today's price. The MC p5 (NT$51.09) already sits just under NT$53.40.
49-83% of the controlling holdcos are pledged. A sharp drawdown could trigger forced selling and an air-pocket in a ~NT$5M/day-turnover micro-cap where the family is levered against its own stake.
The shift from cash to stock dividends (+7M shares in H2-25) mechanically dilutes cash-per-share each year it continues, eroding the per-share claim even on a flat business.
The 2025 margin uptick to 8.3% was largely TWD strength lowering imported-component costs. A persistently strong TWD does not help; a reversal compresses the margin back toward the trough.
One analyst, zero submitted estimates, no Value-Up plan, no activist, no merger. YAMADA is operational, not a governance catalyst — cheapness can persist for years without a trigger. A risk to timing, not to capital.
10-year forecast
Revenue creeps from NT$6.6B to ~NT$7.9B over the decade (~1.8% CAGR) while the operating margin drifts down from the FX-flattered 8.2% to the 7.5% target — a flat business with a deliberately disciplined margin, not a turnaround.
Monte Carlo distribution
Even the modeled spread brackets the price: the Monte Carlo p5 (NT$51.09) sits slightly below today's NT$53.40 and P(intrinsic<market)=12% — and that distribution is the un-anchored operating-ceiling spread, before the cash-to-minority haircut. The realistic downside is worse than the histogram shows, because it discounts cash the minority never receives.
Mean NT$60.56 ± NT$6.10/sh, 1000 iterations (0 failed). P(intrinsic < market NT$53.40) = 12.0%.
Cost of capital build
| Risk-free rate | 2.31% |
| Mature-market ERP | 4.23% |
| Levered β | 1.05 |
| Weighted CRP | 0.78% |
| Cost of equity | 7.57% |
| Pre-tax cost of debt (synth Aaa/AAA) | 2.71% |
| D / V | ~17% |
| WACC | 6.65% |
Full year-by-year DCF
| Year | Revenue | Op mgn | EBIT | EBIT(1−t) | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | NT$6.60B | 8.22% | NT$542M | NT$443M | NT$68M | NT$375M | NT$352M |
| 2 | NT$6.73B | 8.14% | NT$548M | NT$448M | NT$69M | NT$378M | NT$332M |
| 3 | NT$6.86B | 8.06% | NT$553M | NT$452M | NT$71M | NT$381M | NT$314M |
| 4 | NT$7.00B | 7.98% | NT$559M | NT$457M | NT$72M | NT$384M | NT$297M |
| 5 | NT$7.14B | 7.90% | NT$564M | NT$461M | NT$74M | NT$387M | NT$281M |
| 6 | NT$7.29B | 7.82% | NT$570M | NT$464M | NT$75M | NT$388M | NT$264M |
| 7 | NT$7.43B | 7.74% | NT$575M | NT$466M | NT$77M | NT$389M | NT$248M |
| 8 | NT$7.58B | 7.66% | NT$581M | NT$468M | NT$78M | NT$390M | NT$233M |
| 9 | NT$7.73B | 7.58% | NT$586M | NT$471M | NT$80M | NT$391M | NT$219M |
| 10 | NT$7.89B | 7.50% | NT$591M | NT$473M | NT$81M | NT$392M | NT$206M |
Methodology & flags
Damodaran FCFF DCF, 10y explicit + perpetuity, in TWD. Risk-free
2.31% (local-currency government bond). Synthetic credit Aaa/AAA.
CRP 0.78% from revenue-weighted country mix × Damodaran 2026 CRPs.
Terminal ROIC faded to 11.40%; 25% governance haircut applied
post-DCF. Monte Carlo: 1000 iterations. Engine v1.0.0 · result:
/Users/valentin/Documents/notes_jiliac_labs/Finance/Damodaran/valuations/heran/output/2026-06-05-result.json
- R&D cap: OFF · Lease cap: OFF · Failure: OFF · ESO: OFF
- Governance haircut: 25% applied post-DCF (NT$80.90 > NT$60.67)
- Sensitivity tornado: not run